Matches in SemOpenAlex for { <https://semopenalex.org/work/W3173350862> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- W3173350862 endingPage "74" @default.
- W3173350862 startingPage "74" @default.
- W3173350862 abstract "Background: Hyperalgesia and allodynia are abnormal sensory signs which are usually seen along neuropathic pain (NP) in patients on paclitaxel (PT) chemotherapy. Pomegranate seed oil (PSO) has been used in the traditional medicine for the different kinds of pain. Nucleo-CMP Forte® (NCF) is a nucleotide-based drug and L-carnitine (LC) is a member of natural compounds have been shown effective in diverse peripheral neuroglial disorders. The aim of this study is to compare the anti-hyperalgesia and anti-allodynia activity of PSO, NCF, and LC in PT-induced neuropathy. Materials and Methods: Thirty adult male mice were divided equally into five groups of six mice in each group as follows: Control (C), PT, PSO (PTpso), NCF (PTn), and LC (PTc) groups. NP was induced by the administration of PT (6 mg/kg, i. p., once weekly) to the mice in all groups except C group. PSO, NCF, and LC were administered orally once daily to mice with PT-induced neuropathy in their corresponding groups. Different behavior parameters were used to test the anti-hyperalgesic and anti-allodynic effect of PSO, NCF, and LC on days 0, 7, 14, 21, and 28 of PT administration. Results: PSO, NCF, and LC significantly attenuated NP induced by PT from day 14 up to 28 days using the different behavioral tests for thermal hyperalgesia and allodynia. Conclusion: PSO, NCF, and LC have significant potential anti-nociceptive and analgesic activity against PT-induced NP and PSO was the most efficacious than NCF and LC." @default.
- W3173350862 created "2021-07-05" @default.
- W3173350862 creator A5023025215 @default.
- W3173350862 date "2021-01-01" @default.
- W3173350862 modified "2023-10-04" @default.
- W3173350862 title "Protection against paclitaxel-induced hyperalgesia and allodynia by pomegranate seed oil, nucleo-cmp forte®, and l-carnitine" @default.
- W3173350862 doi "https://doi.org/10.4103/mjbl.mjbl_71_20" @default.
- W3173350862 hasPublicationYear "2021" @default.
- W3173350862 type Work @default.
- W3173350862 sameAs 3173350862 @default.
- W3173350862 citedByCount "0" @default.
- W3173350862 crossrefType "journal-article" @default.
- W3173350862 hasAuthorship W3173350862A5023025215 @default.
- W3173350862 hasBestOaLocation W31733508621 @default.
- W3173350862 hasConcept C126322002 @default.
- W3173350862 hasConcept C134018914 @default.
- W3173350862 hasConcept C15490471 @default.
- W3173350862 hasConcept C170493617 @default.
- W3173350862 hasConcept C2776694085 @default.
- W3173350862 hasConcept C2777107010 @default.
- W3173350862 hasConcept C2777292972 @default.
- W3173350862 hasConcept C2777883359 @default.
- W3173350862 hasConcept C2779245659 @default.
- W3173350862 hasConcept C2779901536 @default.
- W3173350862 hasConcept C2780820201 @default.
- W3173350862 hasConcept C42219234 @default.
- W3173350862 hasConcept C555293320 @default.
- W3173350862 hasConcept C71924100 @default.
- W3173350862 hasConcept C98274493 @default.
- W3173350862 hasConceptScore W3173350862C126322002 @default.
- W3173350862 hasConceptScore W3173350862C134018914 @default.
- W3173350862 hasConceptScore W3173350862C15490471 @default.
- W3173350862 hasConceptScore W3173350862C170493617 @default.
- W3173350862 hasConceptScore W3173350862C2776694085 @default.
- W3173350862 hasConceptScore W3173350862C2777107010 @default.
- W3173350862 hasConceptScore W3173350862C2777292972 @default.
- W3173350862 hasConceptScore W3173350862C2777883359 @default.
- W3173350862 hasConceptScore W3173350862C2779245659 @default.
- W3173350862 hasConceptScore W3173350862C2779901536 @default.
- W3173350862 hasConceptScore W3173350862C2780820201 @default.
- W3173350862 hasConceptScore W3173350862C42219234 @default.
- W3173350862 hasConceptScore W3173350862C555293320 @default.
- W3173350862 hasConceptScore W3173350862C71924100 @default.
- W3173350862 hasConceptScore W3173350862C98274493 @default.
- W3173350862 hasIssue "2" @default.
- W3173350862 hasLocation W31733508621 @default.
- W3173350862 hasLocation W31733508622 @default.
- W3173350862 hasOpenAccess W3173350862 @default.
- W3173350862 hasPrimaryLocation W31733508621 @default.
- W3173350862 hasRelatedWork W1990267117 @default.
- W3173350862 hasRelatedWork W2035781896 @default.
- W3173350862 hasRelatedWork W2057710964 @default.
- W3173350862 hasRelatedWork W2094749427 @default.
- W3173350862 hasRelatedWork W2095235977 @default.
- W3173350862 hasRelatedWork W2145565627 @default.
- W3173350862 hasRelatedWork W2147909455 @default.
- W3173350862 hasRelatedWork W3023978917 @default.
- W3173350862 hasRelatedWork W4296499271 @default.
- W3173350862 hasRelatedWork W4313584630 @default.
- W3173350862 hasVolume "18" @default.
- W3173350862 isParatext "false" @default.
- W3173350862 isRetracted "false" @default.
- W3173350862 magId "3173350862" @default.
- W3173350862 workType "article" @default.